Investigating NMJ Defects in SMA Following Central and Peripheral SMN Restoration
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 18
- 试验地点
- 1
- 主要终点
- Decrement on repetitive nerve stimulation
研究概览
简要总结
This is an observational study to investigate the improvement of NMJ defects in adult patients with SMA following treatment with Risdiplam. Eligible patients will have received treatment with daily oral Risdiplam after receiving approval through their commercial insurance or drug assistance program. All subjects will be evaluated at one visit. Eligible subjects must have been receiving risdiplam for at least 12 months.
详细描述
This is a proof of concept trial to investigate the impact of FDA approved therapy for adults with SMA on NMJ transmission. The study will enroll genetically confirmed adults with 5 q SMA treated with risdiplam for at least 12 months. Dosing will be weight- based as approved by the FDA (US Prescribing Information).
Assessments will include medical history, general physical and neurological examinations, vital signs, and the recording of adverse events. Diagnostic tests will include repetitive nerve stimulation (RNS), motor unit number estimation (MUNE), and decomposition EMG (dEMG). Further evaluations will utilize the Hammersmith Functional Motor Scale Expanded (HFMSE), the Revised Upper Limb Module (RULM), the modified SMA Functional Rating Scale (SMAFRS), and the Fatigue Severity Scale (FSS). For ambulatory subjects, the assessment will include a six-minute walk test, while for non-ambulatory subjects, the Children's Hospital of Philadelphia Adult/Adolescent Test of Neuromuscular Disorders (CHOP INTEND) will be performed. Handheld dynamometry will be used to measure strength in bilateral shoulder abduction, elbow flexion, elbow extension, hip flexion, hip abduction, hip adduction, knee flexion, and knee extension.
The study aims to investigate the impact of Risdiplam on neuromuscular junction (NMJ) function by assessing changes in the percent decrement of the compound muscle action potential amplitude, as measured through 3 Hz repetitive nerve stimulation (RNS) of the spinal accessory nerve. These results will be compared to historical controls. Additionally, the study will evaluate the differences in strength, motor function, and electrophysiological test scores between groups, which will be stratified based on a 10% decrement cutoff. Further analysis will explore the association between these measures and percent decrement among ambulatory and non-ambulatory patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Signed Informed Consent Form
- •Age 18-70 years at time of signing Informed Consent Form
- •Able and willing to provide written informed consent and to comply with the program protocol according to ICH and local regulations
- •Ability to comply with the study protocol, in the investigator's judgment
- •Adequately recovered from any acute illness at the time of screening, and considered clinically well enough to participate, in the opinion of the treating physician
- •Patients with retinopathy of prematurity should have evidence of stable disease
- •Genetic confirmation of 5q SMA documented on standard genetic tests for the disorder
- •Treated with risdiplam for a duration of 12 months or longer
排除标准
- •Treatment with an investigational therapy within 180 days prior to initiation of study drug
- •History of established diagnosis of neuromuscular junction disorder
- •Co-morbid conditions that preclude travel or testing
- •Patients who are, in the investigator's opinion, mentally or legally incapacitated to provide an informed consent
结局指标
主要结局
Decrement on repetitive nerve stimulation
时间窗: Baseline
Change in the percent decrement of the compound muscle action potential amplitude assessed using 3 Hz repetitive nerve stimulation (RNS) of the spinal accessory nerve compared to historical controls. If CMAP amplitude is absent at spinal accessory nerve, SMA, ulnar CMAP will be used to assess NMJ transmission.
次要结局
- Children's Hospital of Philadelphia - Adult Test of Neuromuscular Disorders (CHOP-ATEND)(Baseline)
- Six Minute Walk Test (6MWT) Total Distance(Baseline)
- Six Minute Walk Test Difference in Distance Between the First and Final minute(Baseline)
- Modified Spinal Muscular Atrophy Function Rating Scale (SMA-FRS)(Baseline)
- Revised Upper Limb Module (RULM)(Baseline)
- Hammersmith Functional Rating Scale (HFMSE)(Baseline)
- Fatigue Severity Scale (FSS)(Baseline)
- Strength Measure using Hand Held Dynamometry(Baseline)
- Ulnar Compound Muscle Action Potential (Ulnar -CMAP)(Baseline)
- Motor Unit Number Estimation (MUNE)(Baseline)
研究者
Bakri Elsheikh
Professor of Neurology
Ohio State University